AbCellera Biologics Inc. (ABCL)
NASDAQ: ABCL · Real-Time Price · USD
4.150
+0.330 (8.64%)
At close: Apr 30, 2026, 4:00 PM EDT
4.160
+0.010 (0.24%)
After-hours: Apr 30, 2026, 4:11 PM EDT
AbCellera Biologics Market Cap
AbCellera Biologics has a market cap or net worth of $1.26 billion as of April 30, 2026. Its market cap has increased by 73.24% in one year.
Market Cap
1.26B
Enterprise Value
846.29M
1-Year Change
73.24%
Ranking
Category
Stock Price
$4.15
Market Cap Chart
Since the IPO on December 11, 2020, AbCellera Biologics's market cap has decreased from $15.66B to $1.26B, a decrease of -91.96%. That is a compound annual growth rate of -37.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 29, 2026 | 1.16B | 13.12% |
| Dec 31, 2025 | 1.02B | 18.29% |
| Dec 31, 2024 | 865.42M | -47.77% |
| Dec 29, 2023 | 1.66B | -42.83% |
| Dec 30, 2022 | 2.90B | -28.02% |
| Dec 31, 2021 | 4.03B | -62.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 11, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MapLight Therapeutics | 1.33B |
| ArriVent BioPharma | 1.33B |
| Corvus Pharmaceuticals | 1.31B |
| Jade Biosciences | 1.30B |
| Novavax | 1.29B |
| Savara | 1.27B |
| Olema Pharmaceuticals | 1.27B |
| DBV Technologies | 1.25B |